nodes	percent_of_prediction	percent_of_DWPC	metapath
Rivaroxaban—ABCB1—Parkinson's disease	0.801	1	CbGaD
Rivaroxaban—Linezolid—MAOB—Parkinson's disease	0.0144	0.588	CrCbGaD
Rivaroxaban—Linezolid—MAOA—Parkinson's disease	0.0101	0.412	CrCbGaD
Rivaroxaban—CYP2J2—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.00173	0.0105	CbGpPWpGaD
Rivaroxaban—CYP3A5—Xenobiotics—CYP2D6—Parkinson's disease	0.00162	0.00984	CbGpPWpGaD
Rivaroxaban—CYP3A4—Codeine and Morphine Metabolism—CYP2D6—Parkinson's disease	0.00157	0.00952	CbGpPWpGaD
Rivaroxaban—CYP3A5—Tamoxifen metabolism—CYP2D6—Parkinson's disease	0.00156	0.00946	CbGpPWpGaD
Rivaroxaban—CYP2J2—Biological oxidations—GSTA4—Parkinson's disease	0.00152	0.00921	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metapathway biotransformation—GSTA4—Parkinson's disease	0.0015	0.00909	CbGpPWpGaD
Rivaroxaban—CYP3A5—Xenobiotics—CYP2E1—Parkinson's disease	0.00148	0.009	CbGpPWpGaD
Rivaroxaban—CYP3A5—Tamoxifen metabolism—CYP2E1—Parkinson's disease	0.00143	0.00865	CbGpPWpGaD
Rivaroxaban—CYP2J2—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.00142	0.00865	CbGpPWpGaD
Rivaroxaban—CYP2J2—Biological oxidations—MAOB—Parkinson's disease	0.00135	0.00821	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—DOCK3—Parkinson's disease	0.00124	0.00752	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—MERTK—Parkinson's disease	0.00124	0.00752	CbGpPWpGaD
Rivaroxaban—CYP3A4—Aflatoxin B1 metabolism—GSTM1—Parkinson's disease	0.00121	0.00734	CbGpPWpGaD
Rivaroxaban—CYP3A4—Codeine and Morphine Metabolism—ABCB1—Parkinson's disease	0.00112	0.0068	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—DGKQ—Parkinson's disease	0.0011	0.0067	CbGpPWpGaD
Rivaroxaban—F10—cardiovascular system—Parkinson's disease	0.00102	0.105	CbGeAlD
Rivaroxaban—CYP2J2—Biological oxidations—CYP2D6—Parkinson's disease	0.00101	0.0061	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000992	0.00602	CbGpPWpGaD
Rivaroxaban—CYP2J2—forebrain—Parkinson's disease	0.000989	0.101	CbGeAlD
Rivaroxaban—CYP2J2—Biological oxidations—CYP2E1—Parkinson's disease	0.00092	0.00558	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000907	0.00551	CbGpPWpGaD
Rivaroxaban—CYP3A4—Fatty Acid Omega Oxidation—CYP2D6—Parkinson's disease	0.000901	0.00547	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.000841	0.0051	CbGpPWpGaD
Rivaroxaban—CYP2J2—cardiovascular system—Parkinson's disease	0.000836	0.0858	CbGeAlD
Rivaroxaban—F10—Metabolism of proteins—HSPA9—Parkinson's disease	0.000828	0.00503	CbGpPWpGaD
Rivaroxaban—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—Parkinson's disease	0.000824	0.005	CbGpPWpGaD
Rivaroxaban—CYP3A5—Constitutive Androstane Receptor Pathway—ABCB1—Parkinson's disease	0.000795	0.00482	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—LRRK2—Parkinson's disease	0.000791	0.0048	CbGpPWpGaD
Rivaroxaban—CYP2J2—Biological oxidations—COMT—Parkinson's disease	0.000762	0.00463	CbGpPWpGaD
Rivaroxaban—CYP2J2—Biological oxidations—GSTP1—Parkinson's disease	0.000759	0.0046	CbGpPWpGaD
Rivaroxaban—CYP2J2—Biological oxidations—MAOA—Parkinson's disease	0.000757	0.00459	CbGpPWpGaD
Rivaroxaban—CYP3A4—Xenobiotics—CYP2D6—Parkinson's disease	0.000754	0.00457	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metapathway biotransformation—COMT—Parkinson's disease	0.000752	0.00456	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000748	0.00454	CbGpPWpGaD
Rivaroxaban—CYP3A4—Estrogen metabolism—NQO1—Parkinson's disease	0.000742	0.0045	CbGpPWpGaD
Rivaroxaban—CYP3A5—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.000734	0.00446	CbGpPWpGaD
Rivaroxaban—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—Parkinson's disease	0.000732	0.00444	CbGpPWpGaD
Rivaroxaban—CYP3A4—Tamoxifen metabolism—CYP2D6—Parkinson's disease	0.000725	0.0044	CbGpPWpGaD
Rivaroxaban—CYP2J2—medulla oblongata—Parkinson's disease	0.000715	0.0733	CbGeAlD
Rivaroxaban—F10—Hemostasis—MAG—Parkinson's disease	0.000711	0.00432	CbGpPWpGaD
Rivaroxaban—CYP2J2—Biological oxidations—GSTM1—Parkinson's disease	0.000697	0.00423	CbGpPWpGaD
Rivaroxaban—F10—head—Parkinson's disease	0.000691	0.0709	CbGeAlD
Rivaroxaban—CYP3A4—Xenobiotics—CYP2E1—Parkinson's disease	0.000689	0.00418	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000688	0.00417	CbGpPWpGaD
Rivaroxaban—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.000673	0.00409	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—GDNF—Parkinson's disease	0.000673	0.00408	CbGpPWpGaD
Rivaroxaban—CYP3A5—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.000664	0.00403	CbGpPWpGaD
Rivaroxaban—CYP3A4—Tamoxifen metabolism—CYP2E1—Parkinson's disease	0.000663	0.00402	CbGpPWpGaD
Rivaroxaban—CYP2J2—midbrain—Parkinson's disease	0.000653	0.067	CbGeAlD
Rivaroxaban—CYP2J2—spinal cord—Parkinson's disease	0.000637	0.0653	CbGeAlD
Rivaroxaban—ABCB1—Allograft Rejection—VIM—Parkinson's disease	0.000633	0.00384	CbGpPWpGaD
Rivaroxaban—CYP3A4—Estrogen metabolism—COMT—Parkinson's disease	0.000621	0.00377	CbGpPWpGaD
Rivaroxaban—CYP3A4—Tryptophan metabolism—DDC—Parkinson's disease	0.000619	0.00376	CbGpPWpGaD
Rivaroxaban—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000616	0.00374	CbGpPWpGaD
Rivaroxaban—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—Parkinson's disease	0.000613	0.00372	CbGpPWpGaD
Rivaroxaban—CYP3A5—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000608	0.00369	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—RPL6—Parkinson's disease	0.00059	0.00358	CbGpPWpGaD
Rivaroxaban—ABCB1—HIF-1-alpha transcription factor network—CP—Parkinson's disease	0.000589	0.00357	CbGpPWpGaD
Rivaroxaban—CYP3A4—Estrogen metabolism—GSTM1—Parkinson's disease	0.000568	0.00345	CbGpPWpGaD
Rivaroxaban—CYP2J2—head—Parkinson's disease	0.000566	0.0581	CbGeAlD
Rivaroxaban—ABCB1—Allograft Rejection—HLA-DRA—Parkinson's disease	0.00056	0.0034	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—ATP6AP2—Parkinson's disease	0.00056	0.0034	CbGpPWpGaD
Rivaroxaban—CYP3A5—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.000546	0.00331	CbGpPWpGaD
Rivaroxaban—CYP2J2—nervous system—Parkinson's disease	0.000537	0.0551	CbGeAlD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000525	0.00319	CbGpPWpGaD
Rivaroxaban—CYP3A4—Tryptophan metabolism—MAOB—Parkinson's disease	0.000521	0.00316	CbGpPWpGaD
Rivaroxaban—CYP2J2—central nervous system—Parkinson's disease	0.000517	0.053	CbGeAlD
Rivaroxaban—F10—Metabolism of proteins—DCTN1—Parkinson's disease	0.000512	0.00311	CbGpPWpGaD
Rivaroxaban—CYP2J2—cerebellum—Parkinson's disease	0.000505	0.0518	CbGeAlD
Rivaroxaban—CYP3A5—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000499	0.00303	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—ND3—Parkinson's disease	0.000494	0.003	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—MCCC1—Parkinson's disease	0.000494	0.003	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—TALDO1—Parkinson's disease	0.000465	0.00282	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—OMD—Parkinson's disease	0.000465	0.00282	CbGpPWpGaD
Rivaroxaban—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—Parkinson's disease	0.000451	0.00274	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—FGB—Parkinson's disease	0.000449	0.00272	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—RPL23A—Parkinson's disease	0.000447	0.00271	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—RPL14—Parkinson's disease	0.000447	0.00271	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—NDUFB11—Parkinson's disease	0.000441	0.00267	CbGpPWpGaD
Rivaroxaban—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABL1—Parkinson's disease	0.00044	0.00267	CbGpPWpGaD
Rivaroxaban—CYP3A5—Biological oxidations—GSTA4—Parkinson's disease	0.000438	0.00266	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000432	0.00262	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—GCH1—Parkinson's disease	0.00042	0.00255	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—RPS8—Parkinson's disease	0.000417	0.00253	CbGpPWpGaD
Rivaroxaban—CYP3A5—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000411	0.00249	CbGpPWpGaD
Rivaroxaban—CYP2J2—brain—Parkinson's disease	0.00041	0.0421	CbGeAlD
Rivaroxaban—CYP3A5—Biological oxidations—MAOB—Parkinson's disease	0.00039	0.00237	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000379	0.0023	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—GBA—Parkinson's disease	0.000375	0.00227	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—FBP1—Parkinson's disease	0.000375	0.00227	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—DBH—Parkinson's disease	0.000375	0.00227	CbGpPWpGaD
Rivaroxaban—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—Parkinson's disease	0.00037	0.00224	CbGpPWpGaD
Rivaroxaban—CYP3A4—Tryptophan metabolism—CYP2E1—Parkinson's disease	0.000354	0.00215	CbGpPWpGaD
Rivaroxaban—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	0.000352	0.00214	CbGpPWpGaD
Rivaroxaban—ABCB1—HIF-1-alpha transcription factor network—HMOX1—Parkinson's disease	0.00035	0.00212	CbGpPWpGaD
Rivaroxaban—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.000341	0.00207	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—SOD1—Parkinson's disease	0.000333	0.00202	CbGpPWpGaD
Rivaroxaban—ABCB1—HIF-1-alpha transcription factor network—EDN1—Parkinson's disease	0.00033	0.002	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—ABL1—Parkinson's disease	0.000318	0.00193	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—IGF2—Parkinson's disease	0.000316	0.00192	CbGpPWpGaD
Rivaroxaban—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.000313	0.0019	CbGpPWpGaD
Rivaroxaban—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.000309	0.00187	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—HGF—Parkinson's disease	0.000299	0.00181	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—MAP3K5—Parkinson's disease	0.000296	0.0018	CbGpPWpGaD
Rivaroxaban—CYP3A5—Biological oxidations—CYP2D6—Parkinson's disease	0.00029	0.00176	CbGpPWpGaD
Rivaroxaban—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000286	0.00174	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000286	0.00174	CbGpPWpGaD
Rivaroxaban—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000282	0.00171	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—DDC—Parkinson's disease	0.000275	0.00167	CbGpPWpGaD
Rivaroxaban—CYP3A5—Biological oxidations—CYP2E1—Parkinson's disease	0.000265	0.00161	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—FASLG—Parkinson's disease	0.000263	0.00159	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000262	0.00159	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—GSTA4—Parkinson's disease	0.00026	0.00158	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000256	0.00156	CbGpPWpGaD
Rivaroxaban—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.000254	0.00154	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—IGF2—Parkinson's disease	0.000249	0.00151	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—MAPT—Parkinson's disease	0.000246	0.00149	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PLA2G6—Parkinson's disease	0.000234	0.00142	CbGpPWpGaD
Rivaroxaban—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000232	0.00141	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—MAOB—Parkinson's disease	0.000231	0.0014	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.00022	0.00134	CbGpPWpGaD
Rivaroxaban—CYP3A5—Biological oxidations—COMT—Parkinson's disease	0.00022	0.00133	CbGpPWpGaD
Rivaroxaban—CYP3A5—Biological oxidations—GSTP1—Parkinson's disease	0.000219	0.00133	CbGpPWpGaD
Rivaroxaban—CYP3A5—Biological oxidations—MAOA—Parkinson's disease	0.000218	0.00132	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metapathway biotransformation—COMT—Parkinson's disease	0.000217	0.00131	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000216	0.00131	CbGpPWpGaD
Rivaroxaban—ABCB1—embryo—Parkinson's disease	0.000209	0.0214	CbGeAlD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.000205	0.00124	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.000205	0.00124	CbGpPWpGaD
Rivaroxaban—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	0.000203	0.00123	CbGpPWpGaD
Rivaroxaban—CYP3A5—Biological oxidations—GSTM1—Parkinson's disease	0.000201	0.00122	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000201	0.00122	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000198	0.0012	CbGpPWpGaD
Rivaroxaban—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000191	0.00116	CbGpPWpGaD
Rivaroxaban—ABCB1—forebrain—Parkinson's disease	0.000185	0.019	CbGeAlD
Rivaroxaban—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	0.000181	0.0011	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—CYP2D6—Parkinson's disease	0.000172	0.00104	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—CTGF—Parkinson's disease	0.000169	0.00102	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—INS—Parkinson's disease	0.000165	0.001	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—CYP2E1—Parkinson's disease	0.000157	0.000955	CbGpPWpGaD
Rivaroxaban—ABCB1—cardiovascular system—Parkinson's disease	0.000156	0.016	CbGeAlD
Rivaroxaban—CYP2J2—Metabolism—NQO1—Parkinson's disease	0.000156	0.000944	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—TH—Parkinson's disease	0.000153	0.00093	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—Parkinson's disease	0.000148	0.0009	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—IL1B—Parkinson's disease	0.000148	0.000899	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—CASP3—Parkinson's disease	0.000148	0.000897	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—CYCS—Parkinson's disease	0.000147	0.000893	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—Parkinson's disease	0.000146	0.000886	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—MCCC1—Parkinson's disease	0.000142	0.000865	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ND3—Parkinson's disease	0.000142	0.000865	CbGpPWpGaD
Rivaroxaban—CYP3A4—nervous system—Parkinson's disease	0.000142	0.0145	CbGeAlD
Rivaroxaban—CYP3A4—central nervous system—Parkinson's disease	0.000137	0.014	CbGeAlD
Rivaroxaban—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	0.000135	0.000818	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—TALDO1—Parkinson's disease	0.000134	0.000813	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—OMD—Parkinson's disease	0.000134	0.000813	CbGpPWpGaD
Rivaroxaban—ABCB1—medulla oblongata—Parkinson's disease	0.000134	0.0137	CbGeAlD
Rivaroxaban—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000133	0.000807	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—COMT—Parkinson's disease	0.00013	0.000791	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—GSTP1—Parkinson's disease	0.00013	0.000787	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—Parkinson's disease	0.00013	0.000787	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—MAOA—Parkinson's disease	0.000129	0.000786	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—HMOX1—Parkinson's disease	0.000128	0.000777	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—NDUFB11—Parkinson's disease	0.000127	0.000771	CbGpPWpGaD
Rivaroxaban—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	0.000123	0.000748	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—ABCB1—Parkinson's disease	0.000123	0.000745	CbGpPWpGaD
Rivaroxaban—ABCB1—midbrain—Parkinson's disease	0.000122	0.0125	CbGeAlD
Rivaroxaban—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000122	0.000738	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GCH1—Parkinson's disease	0.000121	0.000735	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—GSTM1—Parkinson's disease	0.000119	0.000724	CbGpPWpGaD
Rivaroxaban—ABCB1—spinal cord—Parkinson's disease	0.000119	0.0122	CbGeAlD
Rivaroxaban—CYP2J2—Metabolism—GPX1—Parkinson's disease	0.000114	0.000693	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000109	0.000659	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—FBP1—Parkinson's disease	0.000108	0.000655	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—DBH—Parkinson's disease	0.000108	0.000655	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GBA—Parkinson's disease	0.000108	0.000655	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—TNF—Parkinson's disease	0.000108	0.000653	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—MCCC1—Parkinson's disease	0.000108	0.000652	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ND3—Parkinson's disease	0.000108	0.000652	CbGpPWpGaD
Rivaroxaban—ABCB1—head—Parkinson's disease	0.000106	0.0109	CbGeAlD
Rivaroxaban—CYP2J2—Metabolism—MTHFR—Parkinson's disease	0.000105	0.000639	CbGpPWpGaD
Rivaroxaban—CYP3A4—Biological oxidations—COMT—Parkinson's disease	0.000102	0.00062	CbGpPWpGaD
Rivaroxaban—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	0.000102	0.000617	CbGpPWpGaD
Rivaroxaban—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	0.000101	0.000615	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—OMD—Parkinson's disease	0.000101	0.000613	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—TALDO1—Parkinson's disease	0.000101	0.000613	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	0.000101	0.000611	CbGpPWpGaD
Rivaroxaban—ABCB1—nervous system—Parkinson's disease	0.0001	0.0103	CbGeAlD
Rivaroxaban—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	0.0001	0.000608	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—CP—Parkinson's disease	9.99e-05	0.000606	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—APOE—Parkinson's disease	9.81e-05	0.000595	CbGpPWpGaD
Rivaroxaban—ABCB1—central nervous system—Parkinson's disease	9.66e-05	0.00991	CbGeAlD
Rivaroxaban—ABCB1—Metabolism—NDUFB11—Parkinson's disease	9.58e-05	0.000581	CbGpPWpGaD
Rivaroxaban—ABCB1—cerebellum—Parkinson's disease	9.45e-05	0.00969	CbGeAlD
Rivaroxaban—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	9.34e-05	0.000567	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	9.21e-05	0.000559	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GCH1—Parkinson's disease	9.14e-05	0.000555	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—INS—Parkinson's disease	8.38e-05	0.000509	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GBA—Parkinson's disease	8.15e-05	0.000494	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—FBP1—Parkinson's disease	8.15e-05	0.000494	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—DBH—Parkinson's disease	8.15e-05	0.000494	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—DDC—Parkinson's disease	7.93e-05	0.000481	CbGpPWpGaD
Rivaroxaban—ABCB1—brain—Parkinson's disease	7.67e-05	0.00787	CbGeAlD
Rivaroxaban—CYP3A5—Metabolism—GSTA4—Parkinson's disease	7.48e-05	0.000454	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	7.3e-05	0.000443	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	7.12e-05	0.000432	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	6.84e-05	0.000415	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PLA2G6—Parkinson's disease	6.74e-05	0.000409	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	6.71e-05	0.000407	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—MAOB—Parkinson's disease	6.67e-05	0.000405	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ND3—Parkinson's disease	6.62e-05	0.000402	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—MCCC1—Parkinson's disease	6.62e-05	0.000402	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—TALDO1—Parkinson's disease	6.23e-05	0.000378	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—OMD—Parkinson's disease	6.23e-05	0.000378	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—DDC—Parkinson's disease	5.98e-05	0.000363	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	5.94e-05	0.000361	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	5.9e-05	0.000358	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GSTA4—Parkinson's disease	5.65e-05	0.000343	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GCH1—Parkinson's disease	5.63e-05	0.000342	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	5.31e-05	0.000322	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PLA2G6—Parkinson's disease	5.08e-05	0.000309	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—MAOB—Parkinson's disease	5.03e-05	0.000305	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GBA—Parkinson's disease	5.02e-05	0.000305	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—DBH—Parkinson's disease	5.02e-05	0.000305	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—FBP1—Parkinson's disease	5.02e-05	0.000305	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CYP2D6—Parkinson's disease	4.96e-05	0.000301	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CTGF—Parkinson's disease	4.87e-05	0.000295	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CYP2E1—Parkinson's disease	4.53e-05	0.000275	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—NQO1—Parkinson's disease	4.48e-05	0.000272	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—TH—Parkinson's disease	4.42e-05	0.000268	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CYCS—Parkinson's disease	4.24e-05	0.000257	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—COMT—Parkinson's disease	3.76e-05	0.000228	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CYP2D6—Parkinson's disease	3.74e-05	0.000227	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GSTP1—Parkinson's disease	3.74e-05	0.000227	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—MAOA—Parkinson's disease	3.73e-05	0.000226	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—HMOX1—Parkinson's disease	3.69e-05	0.000224	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—DDC—Parkinson's disease	3.68e-05	0.000224	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CTGF—Parkinson's disease	3.67e-05	0.000223	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ABCB1—Parkinson's disease	3.54e-05	0.000215	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GSTA4—Parkinson's disease	3.48e-05	0.000211	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GSTM1—Parkinson's disease	3.44e-05	0.000209	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CYP2E1—Parkinson's disease	3.42e-05	0.000208	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—NQO1—Parkinson's disease	3.38e-05	0.000205	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—TH—Parkinson's disease	3.33e-05	0.000202	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GPX1—Parkinson's disease	3.29e-05	0.0002	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CYCS—Parkinson's disease	3.2e-05	0.000194	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	3.13e-05	0.00019	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—MAOB—Parkinson's disease	3.1e-05	0.000188	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—MTHFR—Parkinson's disease	3.04e-05	0.000184	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—COMT—Parkinson's disease	2.84e-05	0.000172	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—APOE—Parkinson's disease	2.83e-05	0.000172	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GSTP1—Parkinson's disease	2.82e-05	0.000171	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—MAOA—Parkinson's disease	2.82e-05	0.000171	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—HMOX1—Parkinson's disease	2.78e-05	0.000169	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GSTM1—Parkinson's disease	2.59e-05	0.000157	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GPX1—Parkinson's disease	2.48e-05	0.000151	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—INS—Parkinson's disease	2.42e-05	0.000147	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	2.3e-05	0.00014	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—MTHFR—Parkinson's disease	2.29e-05	0.000139	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CTGF—Parkinson's disease	2.26e-05	0.000137	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—APOE—Parkinson's disease	2.13e-05	0.000129	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	2.11e-05	0.000128	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—NQO1—Parkinson's disease	2.08e-05	0.000126	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—TH—Parkinson's disease	2.05e-05	0.000125	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CYCS—Parkinson's disease	1.97e-05	0.00012	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—INS—Parkinson's disease	1.82e-05	0.000111	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—COMT—Parkinson's disease	1.75e-05	0.000106	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GSTP1—Parkinson's disease	1.74e-05	0.000106	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—MAOA—Parkinson's disease	1.73e-05	0.000105	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—HMOX1—Parkinson's disease	1.71e-05	0.000104	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ABCB1—Parkinson's disease	1.65e-05	9.99e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GSTM1—Parkinson's disease	1.6e-05	9.7e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GPX1—Parkinson's disease	1.53e-05	9.28e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—MTHFR—Parkinson's disease	1.41e-05	8.57e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—APOE—Parkinson's disease	1.31e-05	7.98e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—INS—Parkinson's disease	1.12e-05	6.81e-05	CbGpPWpGaD
